Abstract

alpha-Hederin, a triterpene saponin, is reported to have antitumor activities; however, the mechanism underlying its therapeutic effects is not known. In this study, we examine the effects of alpha-hederin on the release of nitric oxide (NO) and the level of inducible nitric oxide synthase (iNOS) gene expression in mouse macrophages. alpha-Hederin elicited a dose-dependent increase in NO secretion. Reverse-transcription polymerase chain reaction showed that the increased NO secretion was due to an increase in iNOS mRNA. Transient expression assays with NF-kappa B binding sites linked to the luciferase gene revealed that the increased level of iNOS mRNA induced by alpha-hederin was mediated by the NF-kappa B transcription factor complex. These results demonstrate that alpha-hederin stimulates NO release and is able to upregulate iNOS expression through NF-kappa B transactivation, which may be a mechanism, whereby alpha-hederin elicits its biological effects.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.